期刊文献+

人乙酰肝素酶的原核表达及重组表达产物的免疫原性鉴定 被引量:1

Prokaryotic expression of human heparanase protein and identification of the expressed product immunogenicity
原文传递
导出
摘要 目的重组并原核表达人乙酰肝素酶(HPA),并对重组产物r HPA进行免疫原性鉴定,获得足够的乙酰肝素酶为其功能研究奠定基础。方法利用包含HPA全长序列质粒为模板,扩增肝素酶c DNA片段,将其插入表达载体p ET42a,转化到大肠杆菌BL21DE3中,0.5 mmol/L的IPTG诱导表达。SDS-PAGE检测目的重组蛋白表达情况,NiNTA亲和层析法提纯r HPA,Western Blot和ELISA检测r HPA的免疫原性。结果成功构建了人乙酰肝素酶原核表达系统,r HPA表达量为细菌总蛋白的23.4%,SDS-PAGE显示提纯后的r HPA为单一的蛋白条带。鼠抗人HPA能有效识别r HPA。结论所构建的人乙酰肝素酶原核表达系统能高效表达r HPA,表达的产物有良好的免疫原性。 Objective Recombinant and prokaryotic expression were conducted on human heparanase( HPA),and the immunogenicity identification on the r HPA of recombinant product,so as to get enough heparanase to lay the foundation for the study of its function. Methods Using the full length HPA plasmid as template,the c DNA fragment of HPA was amplified,and the expression of p ET42 a was added into p ET42 a vector and transformed into E. coli BL21DE3,and then induced for the expression by 0. 5 mmol / L of IPTG. SDS- PAGE was used to measure the expression of target recombinant protein,Ni- NTA affinity chromatography was applied to extract r HPA. Western blot and ELISA were applied to identify immunogenicity of r HPA. Results The HPA prokaryotic expression systems was successfully built,the expression of r HPA was approximately 23. 4% of the total bacterial proteins. The extracted r HPA showed a single protein band in gel after SDS- PAGE. The expression output of r HPA reacted with anti- heparanase antibody. Conclusion The constructed HPA prokaryotic expression system enables to express r HPA with high efficiency,and r HPA has good immunological characteristics of heparanase.
出处 《中国卫生检验杂志》 CAS 2015年第24期4292-4294,共3页 Chinese Journal of Health Laboratory Technology
基金 浙江省医药卫生科学研究基金(2013KYA047)
关键词 乙酰肝素酶 重组表达 免疫原性 Heparanase Recombinant expression Immunogenicity
  • 相关文献

参考文献10

  • 1Liu H, Chen X, Gao W, et al. The expression of heparanase and microRNA- 1258 in human non - small cell lung cancer [ J ]. Tumor Biology, 2012, 33(5) : 1327 - 1334.
  • 2Nadir Y, Brenner B. Heparanase coagulation and cancer progres- sion [ J]. Best Praet Res Clin Haematol, 2009, 22 (1) : 85 -92.
  • 3Nadir Y, Brenner B Heparanase multiple effects in cancer [ J]. Thromb Res, 2014, 133(2) : $90 - $94.
  • 4Shafat I, Barak AB, Pastovsky S, et al. Heparanase levels are ele- vated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment [ J ]. Neoplasia, 2007, 9 ( 11 ) : 909 -916.
  • 5Vlodavsky I, Elkin M, Abboud - Jarrous G, et al. Heparanase : one molecule with multiple functions in cancer progression [ J ]. Connect Tissue Res, 2008, 49(3) : 207 -210.
  • 6Li H, Li H, Qu H, et al. Suramin inhibits cell proliferatian in o- varian and cervical cancer by down regulating heparanase expression [J]. Cancer Cell Int, 2015, 15(52) : 1 - 11.
  • 7Yu Y, Irie F. Heparan sulfate proteoglycans in central synapses [J]. Glycosc Biol Med, 2014, 5(2) : 573 -580.
  • 8Chen B, Chan XP, Wu MS, et al. Expressions of heparanase and upstream stimulatory factor in hepatocellular carcinoma[ J]. Euro J Med Res, 2014, 19(1) : 1 -8.
  • 9Vlodavsky I, Abboud -Jarrous G, Elkin M, et al. The impact of heparanese and heparin on cancer metastasis and angiogenesis [ J ]. Pathophysiol Haemost Thromb, 2006, 35 ( 1/2 ) : 116 - 127.
  • 10Shafat I, Zcharia E, Nisman B, et al. An ELISA method for the detection and quantification of human heparanase [ J ]. Bioehem Biophys Ras Commun, 2006, 341 (4): 958-963.

同被引文献12

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部